Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2888
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02939300 | Ipilimumab and Nivolumab in Leptomeningeal Metastases | ||
| NCT01726439 | Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China | ||
| NCT04818151 | Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data | ||
| NCT06851065 | A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States | ||
| NCT07248839 | A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment | ||
| NCT03325257 | Post-ATU Study of Nivolumab | ||
| NCT02756481 | Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela | ||
| NCT00211263 | Bipolar Disorder Research Study for Ages 12 and Older | ||
| NCT00455793 | Subclinical Atherosclerosis in HIV-infected Patients | ||
| NCT02976493 | Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma | ||
| NCT04150471 | Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients | ||
| NCT06476834 | A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants | ||
| NCT02514304 | Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding | ||
| NCT02992964 | Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers | ||
| NCT04301414 | Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer | ||
| NCT07076121 | A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) | ||
| NCT02159365 | Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients | ||
| NCT06361563 | Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada | ||
| NCT02098616 | Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus | ||
| NCT03048500 | Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | ||
| NCT01129271 | Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects | ||
| NCT04457284 | Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer | ||
| NCT06725264 | Tyrosine Kinase 2 (TYK2) for GA and CS | ||
| NCT00764309 | Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis | ||
| NCT04267393 | Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH) | ||
| NCT03362437 | Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants | ||
| NCT01714739 | A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors | ||
| NCT05421299 | A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate | ||
| NCT06698887 | A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea | ||
| NCT01471704 | Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy Volunteers | ||
| NCT04984733 | Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer | ||
| NCT02243371 | GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab | ||
| NCT02434081 | NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma | ||
| NCT02557100 | Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis | ||
| NCT01369095 | Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression | ||
| NCT01393964 | Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function | ||
| NCT02038946 | Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140) | ||
| NCT06208657 | Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer | ||
| NCT03141177 | A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma | ||
| NCT02097277 | A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes | ||
| NCT00949767 | Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects | ||
| NCT00569036 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors | ||
| NCT02179177 | Apixaban in Patients With Sickle Cell Disease | ||
| NCT03825367 | Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML | ||
| NCT02402699 | Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan | ||
| NCT07017699 | A Study to Assess Deucravacitinib Safety in Pregnancy | ||
| NCT05556265 | A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata | ||
| NCT00501644 | Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | ||
| NCT03168464 | Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) | ||
| NCT00850577 | Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer |
